Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Mathews

Showing results (401-410 of 450) with videos related to

Pageof 45
Sort By:
Annals of Clinical and Translational Neurology|September 11, 2023
Propensity matched comparison of omaveloxolone treatment to Friedreich ataxia natural history dataDavid R Lynch, Angie Goldsberry, Christian Rummey, et al.
Annals of Neurology|October 17, 2020
Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study)David R Lynch, Melanie P Chin, Martin B Delatycki, et al.
International Journal of Epidemiology|June 23, 2023
Variance of age-specific log incidence decomposition (VALID): a unifying model of measured and unmeasured genetic and non-genetic risksJohn L Hopper, James G Dowty, Tuong L Nguyen, et al.
Neurology|December 30, 2004
Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteriaM K Bruno, M Hallett, K Gwinn-Hardy, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|October 13, 2006
The muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): surveillance methodologyLisa A Miller, Paul A Romitti, Christopher Cunniff, et al.
Muscle & Nerve|April 25, 2020
The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID-19 pandemicAravindhan Veerapandiyan, Kathryn R Wagner, Susan Apkon, et al.
Journal of Child Neurology|April 3, 2018
Impact of Mobility Device Use on Quality of Life in Children With Friedreich AtaxiaResham Ejaz, Shiyi Chen, Charles J Isaacs, et al.
Journal of Neuromuscular Diseases|April 12, 2024
Management of Select Adverse Events Following Delandistrogene Moxeparvovec Gene Therapy for Patients With Duchenne Muscular DystrophyCraig M Zaidman, Natalie L Goedeker, Amal A Aqul, et al.
Annals of Clinical and Translational Neurology|March 27, 2019
Randomized, double-blind, placebo-controlled study of interferon-<i>γ</i> 1b in Friedreich AtaxiaDavid R Lynch, Lauren Hauser, Ashley McCormick, et al.
Annals of Neurology|October 1, 2008
Collagen VI glycine mutations: perturbed assembly and a spectrum of clinical severityRishika A Pace, Rachel A Peat, Naomi L Baker, et al.
Pageof 45

Showing results (401-410 of 450) with videos related to

Sort By:
Pageof 45
Annals of Clinical and Translational Neurology|September 11, 2023
Propensity matched comparison of omaveloxolone treatment to Friedreich ataxia natural history dataDavid R Lynch, Angie Goldsberry, Christian Rummey, et al.
Annals of Neurology|October 17, 2020
Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study)David R Lynch, Melanie P Chin, Martin B Delatycki, et al.
International Journal of Epidemiology|June 23, 2023
Variance of age-specific log incidence decomposition (VALID): a unifying model of measured and unmeasured genetic and non-genetic risksJohn L Hopper, James G Dowty, Tuong L Nguyen, et al.
Neurology|December 30, 2004
Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteriaM K Bruno, M Hallett, K Gwinn-Hardy, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|October 13, 2006
The muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): surveillance methodologyLisa A Miller, Paul A Romitti, Christopher Cunniff, et al.
Muscle & Nerve|April 25, 2020
The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID-19 pandemicAravindhan Veerapandiyan, Kathryn R Wagner, Susan Apkon, et al.
Journal of Child Neurology|April 3, 2018
Impact of Mobility Device Use on Quality of Life in Children With Friedreich AtaxiaResham Ejaz, Shiyi Chen, Charles J Isaacs, et al.
Journal of Neuromuscular Diseases|April 12, 2024
Management of Select Adverse Events Following Delandistrogene Moxeparvovec Gene Therapy for Patients With Duchenne Muscular DystrophyCraig M Zaidman, Natalie L Goedeker, Amal A Aqul, et al.
Annals of Clinical and Translational Neurology|March 27, 2019
Randomized, double-blind, placebo-controlled study of interferon-<i>γ</i> 1b in Friedreich AtaxiaDavid R Lynch, Lauren Hauser, Ashley McCormick, et al.
Annals of Neurology|October 1, 2008
Collagen VI glycine mutations: perturbed assembly and a spectrum of clinical severityRishika A Pace, Rachel A Peat, Naomi L Baker, et al.
Pageof 45